Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. (PTIX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Protagenic Therapeutics, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Exchange
- Nasdaq
- CEO
- Garo H. Armen
- Employees
- 1
- IPO date
- 27 Apr 2021
- ISIN
- US74365N1110
- Website
- protagenic.com
Frequently asked questions
Where is Protagenic Therapeutics, Inc. stock listed?
Protagenic Therapeutics, Inc. (PTIX) is listed on Nasdaq.